Research Mentor(s)
Spiegel, P. Clint
Description
Blood coagulation factor VIII is an essential cofactor in the mammalian blood-clotting cascade. FVIII must bind the phospholipid membrane of activated platelets to function as a cofactor for FIXa. The blood coagulation cascade culminates in the formation of a stable blood clot. In humans, the C1 and C2 domains are implicated in binding phospholipid membranes, however the relative contribution of different residues in the lipid-binding mechanism is unclear. Using site-directed mutagenesis, expression of the isolated C1 and C2 domains in Escherichia coli cells, protein purification with metal affinity chromatography, electrospray ionization mass spectrometry, enzyme-linked immunosorbent assays, liposome sedimentation assays, pull down assays, circular dichroism and intrinsic tryptophan fluorescence, we compare relative binding affinities and stability of five mutations on the C1 and C2 domains. Three of the mutations are on the C2 domain: R2320S, R2320T, and R2215A. The other two mutations are on the C1 domain: R2163H and R2159H. Our results combined with the crystal structure of C1 and C2 soaked with O-phosphatidylserine moieties will help elucidate the roles of these residues in the function and stability of FVIII with regards to Hemophilia A.
Document Type
Event
Start Date
17-5-2017 12:00 PM
End Date
17-5-2017 3:00 PM
Department
Chemistry
Genre/Form
student projects; posters
Subjects – Topical (LCSH)
Blood coagulation factor VIII; Blood proteins--Structure; Hemophilia--Treatment
Type
Image
Rights
Copying of this document in whole or in part is allowable only for scholarly purposes. It is understood, however, that any copying or publication of this documentation for commercial purposes, or for financial gain, shall not be allowed without the author's written permission.
Language
English
Format
application/pdf
Included in
Lipid Binding Studies of Blood Coagulation Factor VIII C1 and C2 Domains
Blood coagulation factor VIII is an essential cofactor in the mammalian blood-clotting cascade. FVIII must bind the phospholipid membrane of activated platelets to function as a cofactor for FIXa. The blood coagulation cascade culminates in the formation of a stable blood clot. In humans, the C1 and C2 domains are implicated in binding phospholipid membranes, however the relative contribution of different residues in the lipid-binding mechanism is unclear. Using site-directed mutagenesis, expression of the isolated C1 and C2 domains in Escherichia coli cells, protein purification with metal affinity chromatography, electrospray ionization mass spectrometry, enzyme-linked immunosorbent assays, liposome sedimentation assays, pull down assays, circular dichroism and intrinsic tryptophan fluorescence, we compare relative binding affinities and stability of five mutations on the C1 and C2 domains. Three of the mutations are on the C2 domain: R2320S, R2320T, and R2215A. The other two mutations are on the C1 domain: R2163H and R2159H. Our results combined with the crystal structure of C1 and C2 soaked with O-phosphatidylserine moieties will help elucidate the roles of these residues in the function and stability of FVIII with regards to Hemophilia A.
Comments
Outstanding Poster Award Recipient